End-of-Life Care for Patients With Metastatic Renal Cell Carcinoma in the Era of Oral Anticancer Therapy.

Hannah E Dzimitrowicz,Lauren E Wilson,Bradford E Jackson,Lisa P Spees,Christopher D Baggett,Melissa A Greiner,Deborah R Kaye,Tian Zhang,Daniel George,Charles D Scales,Jessica E Pritchard,Michael S Leapman,Cary P Gross,Michaela A Dinan,Stephanie B Wheeler

JCO oncology practice（2023）

引用 1|浏览44

暂无评分

摘要

Patients with mRCC who received OAAs and younger patients experienced more aggressive EOL care, suggesting opportunities to optimize high-quality EOL care in these groups.

查看译文

关键词

metastatic renal cell carcinoma,end-of-life

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要